DNA R&D to Revenue
Ginkgo Bioworks Holdings Inc Class · R&D to Revenue
DNA R&D to Revenue
Latest reported229.26%period ending
DNA Quarterly R&D/Revenue (143.07% → 229.26%)
Latest values, visible window
High-resolution chart · PNG
DNA r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 229.2618% | |
| 256.3418% | |
| 150.0988% | |
| 178.5746% | |
| 107.5921% | |
| 146.7838% | |
| 174.1898% | |
| 86.4789% | |
| 238.8019% | |
| 359.6273% | |
| 336.7515% | |
| 282.6303% | |
| 179.081% | |
| 201.5303% | |
| 184.316% | |
| 393.7769% | |
| 200.5691% | |
| 192.1416% | |
| 663.3433% | |
| 68.3172% | |
| 119.2387% | |
| 135.1226% | |
| 190.8759% | |
| 271.1622% | |
| 317.5244% | |
| 143.068% |